1993
DOI: 10.1097/00007691-199310000-00004
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacokinetic Interaction Between High-Dose Methotrexate and Amoxycillin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
32
0
4

Year Published

2004
2004
2017
2017

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 75 publications
(36 citation statements)
references
References 0 publications
0
32
0
4
Order By: Relevance
“…31) Amoxicillin decreases the renal clearance of methotrexate, probably due to a competition at the common tubular secretion system. 32) However, the renal excretion of sodium diclofenac is negligible. 8) Thus, an increase in the amoxicillin renal clearance caused by diclofenac could be improbable.…”
Section: )mentioning
confidence: 99%
“…31) Amoxicillin decreases the renal clearance of methotrexate, probably due to a competition at the common tubular secretion system. 32) However, the renal excretion of sodium diclofenac is negligible. 8) Thus, an increase in the amoxicillin renal clearance caused by diclofenac could be improbable.…”
Section: )mentioning
confidence: 99%
“…MTX inhibits dihydrofolate reductase and is used widely for cancer chemotherapy (Frei et al, 1975;Jackson, 1984). Combined administration of MTX with other drugs, such as nonsteroidal anti-inflammatory drugs (NSAIDs) (Ellison and Servi, 1985;Maiche, 1986;Thyss et al, 1986;Ng et al, 1987;Tracy et al, 1992), penicillin antibiotics (Ronchera et al, 1993;Yamamoto et al, 1997;Titier et al, 2002), probenecid (Aherne et al, 1978), and ciprofloxacin (Dalle et al, 2002) can result in severe and life-threatening drug interactions. Of the drugs affecting the pharmacokinetics of MTX, NSAIDs have been well documented.…”
Section: Introductionmentioning
confidence: 99%
“…Several drugs such as nonsteroidal anti-inflammatory drugs [4], probenecid [5] or penicillin [6,7] are known to reduce methotrexate renal elimination. In cancer patients, drug interactions have also been reported between methotrexate, or its main metabolite 7-hydroxymethotrexate, and benzimidazoles (omeprazole and pantoprazole), resulting in clinically relevant myelosuppression with systemic infections and severe mucositis.…”
Section: Introductionmentioning
confidence: 99%